Damien McDevittFounder

United States - San Diego Metropolitan Area

Accomplished CEO and strategist with 24 years in healthcare and a distinguished reputation for working across multiple therapeutic areas with significant success in pharmaceutical R&D, commercialization, business strategy, and Corp Dev/BD. Highly professional, results-driven team player recognized as a versatile and pragmatic leader.

Multiple executive leadership roles in Biotech and Big Pharma: Aspen Neurosciences- CEO, Akcea – CEO; Ionis – CBO; Acadia – SVP; GlaxoSmithKline (GSK) – VP for 10 years. Experience from discovery through development to the commercial launch of three medicines (TEGSEDI®, WAYLIVRA®, and NUPLAZID®).

Successful turnaround of Akcea; significantly improved business performance; successful integration into Ionis business.

Demonstrated ability to establish a business (GSK Innovation Center), grow a business (GSK and Acadia R&D pipelines), and turn around a business (Akcea). Demonstrated track record of achievement and consistently rated as “key talent” in all organizations where employed.

Substantial and diverse deal experience, including 75+ transactions: in-licensing, out-licensing, M&A, option-deals, equity, distributorship. Many strategic, high- value/impact deals.